Global Medical Haemostatic Sponge Market Research Report 2022

Report Format: PDF   |   Report ID: 5516119   |   Published Date: August 2022   |   Pages:  103  

Choose License
Due to the COVID-19 pandemic, the global Medical Haemostatic Sponge market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of  % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Medical Haemostatic Sponge market is estimated at US$  million in 2022, while the United States and China are forecast to reach US$  million and US$  million by 2028, respectively. The proportion of the United States is  % in 2022, while Chinese percentage is  %, and it is predicted that China market share will reach  % in 2028, trailing a CAGR of  % through the analysis period. As for the Europe Medical Haemostatic Sponge landscape, Germany is projected to reach US$  million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is  % and  % respectively for the next 6-year period.
Gelatin Sponge accounting for  % of the Medical Haemostatic Sponge global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Surgical Wound Care segment is altered to an  % CAGR throughout this forecast period and will hold a share about  % in 2028.
The global major manufacturers of Medical Haemostatic Sponge include Bard, Pfizer, Johnson & Johnson, Baxter, Ferrosan Medical Devices, Gelita Medical, Equimedical, Biocer and Celox, etc. In terms of revenue, the global 3 largest players have a  % market share of Medical Haemostatic Sponge in 2021.
This report focuses on Medical Haemostatic Sponge volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medical Haemostatic Sponge market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Medical Haemostatic Sponge Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Gelatin Sponge
    Chitosan Sponge
    Collagen Sponge
    Others
Segment by Application
    Surgical Wound Care
    General Wound Care
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
By Company
    Bard
    Pfizer
    Johnson & Johnson
    Baxter
    Ferrosan Medical Devices
    Gelita Medical
    Equimedical
    Biocer
    Celox
    Hemostasis
    MBP
    Medira
    Hemotec Medical
    Starch Medical
    Success Pharmaceutical
    Changsha Hairun
1 Medical Haemostatic Sponge Market Overview
    1.1 Product Overview and Scope of Medical Haemostatic Sponge
    1.2 Medical Haemostatic Sponge Segment by Type
        1.2.1 Global Medical Haemostatic Sponge Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Gelatin Sponge
        1.2.3 Chitosan Sponge
        1.2.4 Collagen Sponge
        1.2.5 Others
    1.3 Medical Haemostatic Sponge Segment by Application
        1.3.1 Global Medical Haemostatic Sponge Sales Comparison by Application: (2022-2028)
        1.3.2 Surgical Wound Care
        1.3.3 General Wound Care
    1.4 Global Medical Haemostatic Sponge Market Size Estimates and Forecasts
        1.4.1 Global Medical Haemostatic Sponge Revenue 2017-2028
        1.4.2 Global Medical Haemostatic Sponge Sales 2017-2028
        1.4.3 Medical Haemostatic Sponge Market Size by Region: 2017 Versus 2021 Versus 2028
2 Medical Haemostatic Sponge Market Competition by Manufacturers
    2.1 Global Medical Haemostatic Sponge Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Medical Haemostatic Sponge Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Medical Haemostatic Sponge Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Medical Haemostatic Sponge Manufacturing Sites, Area Served, Product Type
    2.5 Medical Haemostatic Sponge Market Competitive Situation and Trends
        2.5.1 Medical Haemostatic Sponge Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Medical Haemostatic Sponge Players Market Share by Revenue
        2.5.3 Global Medical Haemostatic Sponge Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Haemostatic Sponge Retrospective Market Scenario by Region
    3.1 Global Medical Haemostatic Sponge Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Medical Haemostatic Sponge Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Medical Haemostatic Sponge Market Facts & Figures by Country
        3.3.1 North America Medical Haemostatic Sponge Sales by Country
        3.3.2 North America Medical Haemostatic Sponge Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Medical Haemostatic Sponge Market Facts & Figures by Country
        3.4.1 Europe Medical Haemostatic Sponge Sales by Country
        3.4.2 Europe Medical Haemostatic Sponge Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Medical Haemostatic Sponge Market Facts & Figures by Region
        3.5.1 Asia Pacific Medical Haemostatic Sponge Sales by Region
        3.5.2 Asia Pacific Medical Haemostatic Sponge Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Medical Haemostatic Sponge Market Facts & Figures by Country
        3.6.1 Latin America Medical Haemostatic Sponge Sales by Country
        3.6.2 Latin America Medical Haemostatic Sponge Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Medical Haemostatic Sponge Market Facts & Figures by Country
        3.7.1 Middle East and Africa Medical Haemostatic Sponge Sales by Country
        3.7.2 Middle East and Africa Medical Haemostatic Sponge Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Medical Haemostatic Sponge Historic Market Analysis by Type
    4.1 Global Medical Haemostatic Sponge Sales Market Share by Type (2017-2022)
    4.2 Global Medical Haemostatic Sponge Revenue Market Share by Type (2017-2022)
    4.3 Global Medical Haemostatic Sponge Price by Type (2017-2022)
5 Global Medical Haemostatic Sponge Historic Market Analysis by Application
    5.1 Global Medical Haemostatic Sponge Sales Market Share by Application (2017-2022)
    5.2 Global Medical Haemostatic Sponge Revenue Market Share by Application (2017-2022)
    5.3 Global Medical Haemostatic Sponge Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Bard
        6.1.1 Bard Corporation Information
        6.1.2 Bard Description and Business Overview
        6.1.3 Bard Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Bard Medical Haemostatic Sponge Product Portfolio
        6.1.5 Bard Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Pfizer Medical Haemostatic Sponge Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Johnson & Johnson
        6.3.1 Johnson & Johnson Corporation Information
        6.3.2 Johnson & Johnson Description and Business Overview
        6.3.3 Johnson & Johnson Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Johnson & Johnson Medical Haemostatic Sponge Product Portfolio
        6.3.5 Johnson & Johnson Recent Developments/Updates
    6.4 Baxter
        6.4.1 Baxter Corporation Information
        6.4.2 Baxter Description and Business Overview
        6.4.3 Baxter Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Baxter Medical Haemostatic Sponge Product Portfolio
        6.4.5 Baxter Recent Developments/Updates
    6.5 Ferrosan Medical Devices
        6.5.1 Ferrosan Medical Devices Corporation Information
        6.5.2 Ferrosan Medical Devices Description and Business Overview
        6.5.3 Ferrosan Medical Devices Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Ferrosan Medical Devices Medical Haemostatic Sponge Product Portfolio
        6.5.5 Ferrosan Medical Devices Recent Developments/Updates
    6.6 Gelita Medical
        6.6.1 Gelita Medical Corporation Information
        6.6.2 Gelita Medical Description and Business Overview
        6.6.3 Gelita Medical Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Gelita Medical Medical Haemostatic Sponge Product Portfolio
        6.6.5 Gelita Medical Recent Developments/Updates
    6.7 Equimedical
        6.6.1 Equimedical Corporation Information
        6.6.2 Equimedical Description and Business Overview
        6.6.3 Equimedical Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Equimedical Medical Haemostatic Sponge Product Portfolio
        6.7.5 Equimedical Recent Developments/Updates
    6.8 Biocer
        6.8.1 Biocer Corporation Information
        6.8.2 Biocer Description and Business Overview
        6.8.3 Biocer Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Biocer Medical Haemostatic Sponge Product Portfolio
        6.8.5 Biocer Recent Developments/Updates
    6.9 Celox
        6.9.1 Celox Corporation Information
        6.9.2 Celox Description and Business Overview
        6.9.3 Celox Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Celox Medical Haemostatic Sponge Product Portfolio
        6.9.5 Celox Recent Developments/Updates
    6.10 Hemostasis
        6.10.1 Hemostasis Corporation Information
        6.10.2 Hemostasis Description and Business Overview
        6.10.3 Hemostasis Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Hemostasis Medical Haemostatic Sponge Product Portfolio
        6.10.5 Hemostasis Recent Developments/Updates
    6.11 MBP
        6.11.1 MBP Corporation Information
        6.11.2 MBP Medical Haemostatic Sponge Description and Business Overview
        6.11.3 MBP Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 MBP Medical Haemostatic Sponge Product Portfolio
        6.11.5 MBP Recent Developments/Updates
    6.12 Medira
        6.12.1 Medira Corporation Information
        6.12.2 Medira Medical Haemostatic Sponge Description and Business Overview
        6.12.3 Medira Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Medira Medical Haemostatic Sponge Product Portfolio
        6.12.5 Medira Recent Developments/Updates
    6.13 Hemotec Medical
        6.13.1 Hemotec Medical Corporation Information
        6.13.2 Hemotec Medical Medical Haemostatic Sponge Description and Business Overview
        6.13.3 Hemotec Medical Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Hemotec Medical Medical Haemostatic Sponge Product Portfolio
        6.13.5 Hemotec Medical Recent Developments/Updates
    6.14 Starch Medical
        6.14.1 Starch Medical Corporation Information
        6.14.2 Starch Medical Medical Haemostatic Sponge Description and Business Overview
        6.14.3 Starch Medical Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Starch Medical Medical Haemostatic Sponge Product Portfolio
        6.14.5 Starch Medical Recent Developments/Updates
    6.15 Success Pharmaceutical
        6.15.1 Success Pharmaceutical Corporation Information
        6.15.2 Success Pharmaceutical Medical Haemostatic Sponge Description and Business Overview
        6.15.3 Success Pharmaceutical Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Success Pharmaceutical Medical Haemostatic Sponge Product Portfolio
        6.15.5 Success Pharmaceutical Recent Developments/Updates
    6.16 Changsha Hairun
        6.16.1 Changsha Hairun Corporation Information
        6.16.2 Changsha Hairun Medical Haemostatic Sponge Description and Business Overview
        6.16.3 Changsha Hairun Medical Haemostatic Sponge Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Changsha Hairun Medical Haemostatic Sponge Product Portfolio
        6.16.5 Changsha Hairun Recent Developments/Updates
7 Medical Haemostatic Sponge Manufacturing Cost Analysis
    7.1 Medical Haemostatic Sponge Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Medical Haemostatic Sponge
    7.4 Medical Haemostatic Sponge Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Medical Haemostatic Sponge Distributors List
    8.3 Medical Haemostatic Sponge Customers
9 Medical Haemostatic Sponge Market Dynamics
    9.1 Medical Haemostatic Sponge Industry Trends
    9.2 Medical Haemostatic Sponge Market Drivers
    9.3 Medical Haemostatic Sponge Market Challenges
    9.4 Medical Haemostatic Sponge Market Restraints
10 Global Market Forecast
    10.1 Medical Haemostatic Sponge Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Medical Haemostatic Sponge by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Medical Haemostatic Sponge by Type (2023-2028)
    10.2 Medical Haemostatic Sponge Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Medical Haemostatic Sponge by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Medical Haemostatic Sponge by Application (2023-2028)
    10.3 Medical Haemostatic Sponge Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Medical Haemostatic Sponge by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Medical Haemostatic Sponge by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Medical Haemostatic Sponge Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Medical Haemostatic Sponge Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Medical Haemostatic Sponge Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Medical Haemostatic Sponge Market Competitive Situation by Manufacturers in 2021 Table 5. Global Medical Haemostatic Sponge Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Medical Haemostatic Sponge Sales Market Share by Manufacturers (2017-2022) Table 7. Global Medical Haemostatic Sponge Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Medical Haemostatic Sponge Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Medical Haemostatic Sponge Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Medical Haemostatic Sponge Manufacturing Sites and Area Served Table 11. Manufacturers Medical Haemostatic Sponge Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Medical Haemostatic Sponge by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Haemostatic Sponge as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Medical Haemostatic Sponge Sales by Region (2017-2022) & (K Units) Table 16. Global Medical Haemostatic Sponge Sales Market Share by Region (2017-2022) Table 17. Global Medical Haemostatic Sponge Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Medical Haemostatic Sponge Revenue Market Share by Region (2017-2022) Table 19. North America Medical Haemostatic Sponge Sales by Country (2017-2022) & (K Units) Table 20. North America Medical Haemostatic Sponge Sales Market Share by Country (2017-2022) Table 21. North America Medical Haemostatic Sponge Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Medical Haemostatic Sponge Revenue Market Share by Country (2017-2022) Table 23. Europe Medical Haemostatic Sponge Sales by Country (2017-2022) & (K Units) Table 24. Europe Medical Haemostatic Sponge Sales Market Share by Country (2017-2022) Table 25. Europe Medical Haemostatic Sponge Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Medical Haemostatic Sponge Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Medical Haemostatic Sponge Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Medical Haemostatic Sponge Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Medical Haemostatic Sponge Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Medical Haemostatic Sponge Revenue Market Share by Region (2017-2022) Table 31. Latin America Medical Haemostatic Sponge Sales by Country (2017-2022) & (K Units) Table 32. Latin America Medical Haemostatic Sponge Sales Market Share by Country (2017-2022) Table 33. Latin America Medical Haemostatic Sponge Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Medical Haemostatic Sponge Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Medical Haemostatic Sponge Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Medical Haemostatic Sponge Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Medical Haemostatic Sponge Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Medical Haemostatic Sponge Revenue Market Share by Country (2017-2022) Table 39. Global Medical Haemostatic Sponge Sales by Type (2017-2022) & (K Units) Table 40. Global Medical Haemostatic Sponge Sales Market Share by Type (2017-2022) Table 41. Global Medical Haemostatic Sponge Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Medical Haemostatic Sponge Revenue Share by Type (2017-2022) Table 43. Global Medical Haemostatic Sponge Price by Type (2017-2022) & (US$/Unit) Table 44. Global Medical Haemostatic Sponge Sales (K Units) by Application (2017-2022) Table 45. Global Medical Haemostatic Sponge Sales Market Share by Application (2017-2022) Table 46. Global Medical Haemostatic Sponge Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Medical Haemostatic Sponge Revenue Share by Application (2017-2022) Table 48. Global Medical Haemostatic Sponge Price by Application (2017-2022) & (US$/Unit) Table 49. Bard Corporation Information Table 50. Bard Description and Business Overview Table 51. Bard Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Bard Medical Haemostatic Sponge Product Table 53. Bard Recent Developments/Updates Table 54. Pfizer Corporation Information Table 55. Pfizer Description and Business Overview Table 56. Pfizer Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Pfizer Medical Haemostatic Sponge Product Table 58. Pfizer Recent Developments/Updates Table 59. Johnson & Johnson Corporation Information Table 60. Johnson & Johnson Description and Business Overview Table 61. Johnson & Johnson Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Johnson & Johnson Medical Haemostatic Sponge Product Table 63. Johnson & Johnson Recent Developments/Updates Table 64. Baxter Corporation Information Table 65. Baxter Description and Business Overview Table 66. Baxter Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Baxter Medical Haemostatic Sponge Product Table 68. Baxter Recent Developments/Updates Table 69. Ferrosan Medical Devices Corporation Information Table 70. Ferrosan Medical Devices Description and Business Overview Table 71. Ferrosan Medical Devices Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Ferrosan Medical Devices Medical Haemostatic Sponge Product Table 73. Ferrosan Medical Devices Recent Developments/Updates Table 74. Gelita Medical Corporation Information Table 75. Gelita Medical Description and Business Overview Table 76. Gelita Medical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Gelita Medical Medical Haemostatic Sponge Product Table 78. Gelita Medical Recent Developments/Updates Table 79. Equimedical Corporation Information Table 80. Equimedical Description and Business Overview Table 81. Equimedical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Equimedical Medical Haemostatic Sponge Product Table 83. Equimedical Recent Developments/Updates Table 84. Biocer Corporation Information Table 85. Biocer Description and Business Overview Table 86. Biocer Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Biocer Medical Haemostatic Sponge Product Table 88. Biocer Recent Developments/Updates Table 89. Celox Corporation Information Table 90. Celox Description and Business Overview Table 91. Celox Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Celox Medical Haemostatic Sponge Product Table 93. Celox Recent Developments/Updates Table 94. Hemostasis Corporation Information Table 95. Hemostasis Description and Business Overview Table 96. Hemostasis Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Hemostasis Medical Haemostatic Sponge Product Table 98. Hemostasis Recent Developments/Updates Table 99. MBP Corporation Information Table 100. MBP Description and Business Overview Table 101. MBP Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. MBP Medical Haemostatic Sponge Product Table 103. MBP Recent Developments/Updates Table 104. Medira Corporation Information Table 105. Medira Description and Business Overview Table 106. Medira Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Medira Medical Haemostatic Sponge Product Table 108. Medira Recent Developments/Updates Table 109. Hemotec Medical Corporation Information Table 110. Hemotec Medical Description and Business Overview Table 111. Hemotec Medical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 112. Hemotec Medical Medical Haemostatic Sponge Product Table 113. Hemotec Medical Recent Developments/Updates Table 114. Starch Medical Corporation Information Table 115. Starch Medical Description and Business Overview Table 116. Starch Medical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 117. Starch Medical Medical Haemostatic Sponge Product Table 118. Starch Medical Recent Developments/Updates Table 119. Success Pharmaceutical Corporation Information Table 120. Success Pharmaceutical Description and Business Overview Table 121. Success Pharmaceutical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 122. Success Pharmaceutical Medical Haemostatic Sponge Product Table 123. Success Pharmaceutical Recent Developments/Updates Table 124. Changsha Hairun Corporation Information Table 125. Changsha Hairun Description and Business Overview Table 126. Changsha Hairun Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 127. Changsha Hairun Medical Haemostatic Sponge Product Table 128. Changsha Hairun Recent Developments/Updates Table 129. Production Base and Market Concentration Rate of Raw Material Table 130. Key Suppliers of Raw Materials Table 131. Medical Haemostatic Sponge Distributors List Table 132. Medical Haemostatic Sponge Customers List Table 133. Medical Haemostatic Sponge Market Trends Table 134. Medical Haemostatic Sponge Market Drivers Table 135. Medical Haemostatic Sponge Market Challenges Table 136. Medical Haemostatic Sponge Market Restraints Table 137. Global Medical Haemostatic Sponge Sales Forecast by Type (2023-2028) & (K Units) Table 138. Global Medical Haemostatic Sponge Sales Market Share Forecast by Type (2023-2028) Table 139. Global Medical Haemostatic Sponge Revenue Forecast by Type (2023-2028) & (US$ Million) Table 140. Global Medical Haemostatic Sponge Revenue Market Share Forecast by Type (2023-2028) Table 141. Global Medical Haemostatic Sponge Sales Forecast by Application (2023-2028) & (K Units) Table 142. Global Medical Haemostatic Sponge Sales Market Share Forecast by Application (2023-2028) Table 143. Global Medical Haemostatic Sponge Revenue Forecast by Application (2023-2028) & (US$ Million) Table 144. Global Medical Haemostatic Sponge Revenue Market Share Forecast by Application (2023-2028) Table 145. Global Medical Haemostatic Sponge Sales Forecast by Region (2023-2028) & (K Units) Table 146. Global Medical Haemostatic Sponge Sales Market Share Forecast by Region (2023-2028) Table 147. Global Medical Haemostatic Sponge Revenue Forecast by Region (2023-2028) & (US$ Million) Table 148. Global Medical Haemostatic Sponge Revenue Market Share Forecast by Region (2023-2028) Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Medical Haemostatic Sponge Figure 2. Global Medical Haemostatic Sponge Market Share by Type in 2021 & 2028 Figure 3. Gelatin Sponge Product Picture Figure 4. Chitosan Sponge Product Picture Figure 5. Collagen Sponge Product Picture Figure 6. Others Product Picture Figure 7. Global Medical Haemostatic Sponge Market Share by Application in 2021 & 2028 Figure 8. Surgical Wound Care Figure 9. General Wound Care Figure 10. Global Medical Haemostatic Sponge Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Medical Haemostatic Sponge Market Size (2017-2028) & (US$ Million) Figure 12. Global Medical Haemostatic Sponge Sales (2017-2028) & (K Units) Figure 13. Medical Haemostatic Sponge Sales Share by Manufacturers in 2021 Figure 14. Global Medical Haemostatic Sponge Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Medical Haemostatic Sponge Players: Market Share by Revenue in 2021 Figure 16. Medical Haemostatic Sponge Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Medical Haemostatic Sponge Sales Market Share by Region (2017-2022) Figure 18. Global Medical Haemostatic Sponge Sales Market Share by Region in 2021 Figure 19. Global Medical Haemostatic Sponge Revenue Market Share by Region (2017-2022) Figure 20. Global Medical Haemostatic Sponge Revenue Market Share by Region in 2021 Figure 21. U.S. Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Medical Haemostatic Sponge Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Medical Haemostatic Sponge by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Medical Haemostatic Sponge Figure 47. Manufacturing Process Analysis of Medical Haemostatic Sponge Figure 48. Medical Haemostatic Sponge Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us